Synthetic Compound Reverses Fatty Liver Disease In Lab Tests

Researchers in the U.S. report development of a synthetic compound that reverses the effects of fatty liver disease, a condition that often accompanies obesity and type 2 diabetes. SR9238 suppressed lipid (fat) production in the liver, eliminated inflammation and reversed fat accumulation in lab animals. According to the researchers, mice fed a high-fat diet and the compound for a month reversed the disease without side effects. The researchers also noted that markers for liver damage were also down, so the compound may be a potential treatment for alcohol-related fatty liver damage.